Skip to main content

Table 2 Enrollment lipids and lipoproteins, endothelial, and inflammatory biomarkers by outcome

From: A hypolipoprotein sepsis phenotype indicates reduced lipoprotein antioxidant capacity, increased endothelial dysfunction and organ failure, and worse clinical outcomes

Variable

N

All patients

Rapid recovery

CCI

Early death

p Value*,^

Lipid measures

Total cholesterol

(mg/dL)

171

91 (67, 117)

100 (76, 120)

67 (56, 98)

71 (58, 117)

 < 0.001

HDL-C (mg/dL)

171

19 (8, 30)

22 (10, 32)

14.5 (6, 20)

8 (5, 26)

0.001

LDL-C (mg/dL)

164

43.5 (27, 64)

50 (35, 67)

31 (21, 47)

25 (17, 59)

 < 0.001

Triglycerides (mg/dL)

171

121 (78, 150)

120 (84, 149)

125 (75, 159)

118 (73, 143)

0.657

HDL inflammatory index

169

1.9 (1.2, 3.34)

1.7 (1.2, 3.56)

1.9 (1.3, 3.2)

2.6 (1.67, 3.1)

0.556

PON-1 activity

(nmol/min/ml)

170

54 (29, 107)

66 (37, 115)

37 (25, 66)

43 (13, 83)

0.003

ApoA-1 (ng/mL)

152

1,100,000 (741,249, 1,500,000)

1,300,000 (919,877, 1,600,000)

819,148 (635,390, 1,000,000)

722,862 (564,171.5, 1,090,858.5)

 < 0.001

Endothelial markers

E-selectin (ng/mL)

133

68 (47, 143)

83 (51, 160)

55 (33, 78)

69 (52, 227)

0.025

ICAM (ng/mL)

139

426 (306, 617)

390 (291, 558)

448 (324, 669)

495 (439, 805)

0.055

Inflammatory markers

MPO (µg/L)

150

203 (139, 334)

1889 (130, 323)

245 (161, 405)

277 (175, 459)

0.078

GRO (pg/mL)

152

1081 (537, 2000)

1100 (555, 1787)

1164 (533, 3519)

561 (324, 1189)

0.291

G-CSF (pg/mL)

164

334 (151, 1168)

329 (150, 1111)

335 (142, 799)

919 (181, 587)

0.256

GM-CSF (pg/mL)

164

12 (4, 41)

10 (4, 39)

13 (4, 42)

16 (7, 60)

0.244

IFNy (pg/mL)

164

28 (8, 62)

29 (8, 62)

25 (8, 53)

27 (11, 75)

0.815

IL-10 (pg/mL)

164

74 (31, 179)

64 (29, 161)

77 (52, 163)

291 (37, 1040)

0.082

IL-8 (pg/mL)

164

67 (31, 1501)

44 (23, 1034)

108 (57, 212)

180 (142, 812)

 < 0.001

IL-6 (pg/mL)

164

176 (64, 520)

152 (52, 361)

259 (71, 919)

312 (152, 1986)

0.017

Il-12p70 (pg/mL)

164

12 (4, 27)

11 (4, 26)

12 (4, 22)

13 (4, 55)

0.726

IP-10 (pg/mL)

164

1066 (484, 2738)

981 (441, 2623)

900 (4878, 2192)

2235 (1638, 3807)

0.028

MCP-1 (pg/mL)

164

739 (460, 1732)

669 (441, 1397)

813 (523, 1779)

1246 (701, 3450)

0.071

MIP-1a (pg/mL)

164

8 (3, 18)

8 (3, 20)

6 (4, 12)

16 (8, 31)

0.055

TNFα (pg/mL)

164

70 (45, 138)

70 (40, 137)

63 (46, 118)

116 (63, 200)

0.103

  1. Bold values are significant after Bonferroni correction for multiple comparisons
  2. Data is median (1st quartile, 3rd quartile); *Wilcoxon rank-sum test; ^after Bonferroni adjustment for multiple tests, significant if < 0.002(0.05/47 tests). Comparisons are bivariate between rapid recovery vs. CCI or early death